Uitgebreid zoeken

Instrumenten

Naam	Mnemo	Beurs	Gemiddeld volume	Koers	Type
SUN COMMUNITIES, INC.	S2UI34	Sao Paulo	466	31,29 BRL	Aandeel
SUN COMMUNITIES, INC.	SUI	Nyse +4 Andere	890 032	122,1 USD	Aandeel
SUN COMMUNITIES, INC.	SCZ	Deutsche Boerse AG	-	112 EUR
SUN COMMUNITIES, INC.	SUI *	Mexican S.E.	309	2.237 MXN
SUN COMMUNITIES, INC.	SCZ	BOERSE MUENCHEN	-	112 EUR
SUN COMMUNITIES, INC.	SCZ	Börse Stuttgart	-	111 EUR
SUN LIFE FINANCIAL INC.	SLF.PR.D	Toronto S.E. +1 Andere	9 150	19,14 CAD	Aandeel
SUN LIFE FINANCIAL INC.	SLFIF	OTC Markets	0	13,3 USD
SUN PHARMACEUTICAL INDUSTRIES LTD.	SUNPHARMA	NSE India S.E. +1 Andere	1 759 618	1.532 INR	Aandeel
SUN PHARMACEUTICAL INDUSTRIES LTD.	SUNPHARMA	Bombay S.E.	52 384	1.531 INR
SUN LIFE FINANCIAL INC.	SLF.PR.C	Toronto S.E. +1 Andere	7 714	19,18 CAD	Aandeel
SUN LIFE FINANCIAL INC.	SNLI.F	OTC Markets	0	18,28 USD
SUN LIFE FINANCIAL INC.	SLF.PR.E	Toronto S.E.	8 741	19,2 CAD	Aandeel
SUN LIFE FINANCIAL INC.	SLF.PR.H	Toronto S.E.	3 955	20,25 CAD	Aandeel
SUN LIFE FINANCIAL INC.	SLF	Toronto S.E. +6 Andere	2 378 124	70,37 CAD	Aandeel
SUN LIFE FINANCIAL INC.	SLF	Nyse	890 980	51,46 USD
SUN LIFE FINANCIAL INC.	LIE	Deutsche Boerse AG	-	47,4 EUR
SUN LIFE FINANCIAL INC.	0VJA	London S.E.	343	72,35 CAD
SUN LIFE FINANCIAL INC.	LIE	Börse Stuttgart	-	47,4 EUR
SUN LIFE FINANCIAL INC.	SLF	Philippines S.E.	136	2.800 PHP
SUN LIFE FINANCIAL INC.	LIE	BOERSE MUENCHEN	-	47,4 EUR
SUN LIFE FINANCIAL INC.	SLF.PR.G	Toronto S.E. +1 Andere	35 487	17,25 CAD	Aandeel
SUN LIFE FINANCIAL INC.	SUNFF	OTC Markets	175	11,02 USD
SUN LIFE FINANCIAL INC.	SLF.PR.J	Toronto S.E.	2 852	17,95 CAD	Aandeel

Alles bekijken

Bedrijven (187)

SUN PHARMACEUTICAL INDUSTRIES LTD. 44 123 M $

Sun Pharmaceutical Industries Ltd. is een van de Indiase leiders van farmaceutische groepen. De netto-omzet is als volgt over de productfamilie verdeeld - generieke en OTC-geneesmiddelen (94%): voor de behandeling van cardiologische, psychiatrische, neur ...

SUN COMMUNITIES, INC. 15 246 M $

Sun Communities, Inc. is een volledig geïntegreerde vastgoedbeleggingsmaatschappij (REIT). Het bedrijf bezit gemeenschappen voor huisvesting (MH) en recreatievoertuigen (RV) en jachthavens in de Verenigde Staten, het Verenigd Koninkrijk en Canada. Het bed ...

SUN HUNG KAI PROPERTIES LIMITED 28 106 M $

Sun Hung Kai Properties Limited is gespecialiseerd in de ontwikkeling en promotie van onroerend goed. De netto-omzet kan als volgt worden uitgesplitst naar activiteit - verkoop van vastgoedactiva (47,4%): vastgoedactiva van bedrijven en woningen, hotels, ...

SUN LIFE FINANCIAL INC. 30 056 M $

Sun Life Financial Inc. is een in Canada gevestigde internationale financiële dienstverlener die vermogensbeheer-, vermogens-, verzekerings- en gezondheidsoplossingen biedt aan individuele en institutionele klanten. Haar segmenten zijn Canada, Verenigde S ...

SUN LIFE FINANCIAL INC. 30 056 M $

SUN COMMUNITIES, INC. 15 246 M $

SUN LIFE FINANCIAL INC. 30 056 M $

1234Volgende

Insiders

Maohua Sun

Momenteel is Maohua Sun Chief Operating Officer & Executive Vice President voor Trip.com Group Ltd. Mevrouw Sun behaalde een bachelordiploma aan de Shanghai Jiao Tong University en een MBA aan de China Europe International Business School.

Sun Sun Sze is currently a Director at Well Success Investment Ltd., First Dynamic International Ltd., and Alexon International Ltd.
He was previously the Managing Director & Executive Director at Symphony Holdings Ltd.
from 2014 to 2015.

Familie Sze Sun Sun Tony

Xiaobo Sun

Xiaobo Sun is an Independent Director at China Shenghuo Pharmaceutical Holdings, Inc. since 2011.
Prior to this, he was a Deputy Director at the Chinese Academy of Medical Sciences starting in 2007.
Dr. Sun also served as the President & Chief Executive Officer at Global Pharmatech, Inc. Dr. Sun holds a doctorate degree from Jilin Agricultural University, which was conferred in 2004.

Eugene Sun

Eugene Sun served as the Chief Executive Officer & Director at Melinta Subsidiary Corp.
from 2015 to 2017.
He was also the Independent Director at NVN Liquidation, Inc. from 2018 to 2020.
Prior to that, he was the VP-Global Pharmaceutical Clinical Development at Abbott Laboratories from 2000 to 2011 and the Director at TAP Pharmaceutical Products, Inc. in 2008.
Dr. Sun received his undergraduate degree from Harvard University and his doctorate from New York University School of Medicine.

Lijun Sun

Lijun Sun was the founder of Silicon INSITE, Inc. (founded in 2016) where he held the title of Director & Head-Discovery.
He previously worked as a Senior Director-Chemistry at Shionogi Bioresearch Corp.
from 1997 to 2002.
From 2009 to 2016, he was the Vice President-Chemistry at Synta Pharmaceuticals Corp.
He also served as an Independent Non-Executive Director at TOT BIOPHARM International Co. Ltd.
from 2019 to 2022.
Dr. Sun was a Director-Drug Discovery Center at Beth Israel Deaconess Medical Center, Inc. and an Associate Professor at Harvard Medical School.
Dr. Sun received his doctorate degree from Emory University in 1996 and his graduate degree from Georgetown University in 1992.

Geen resultaten voor deze zoekopdracht